Ivano-Frankivsk State Medical University

Ivano-Frankivsk 76018

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease, Secondary Acute Myeloid Leukemia (Secondary AML, sAML)

Studies at this site

• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed